168PValidation of the MammaTyper® pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC). (23rd October 2018) - Fasching, P A; Laible, M; Weber, K E; Wirtz, R M; Denkert, C; Schlombs, K; Schmatloch, S; Camara, O; Lück, H J; Huober, J; Karn, T; van Mackelenbergh, M T; et al.